CBRN Protection: Managing the Threat of Chemical, Biological, Radioactive and Nuclear Weapons
CBRN Protection: Managing the Threat of Chemical, Biological, Radioactive and Nuclear Weapons Original price was: $87.40.Current price is: $29.99.
Back to products
Anatomy of the Horse
Anatomy of the Horse Original price was: $85.31.Current price is: $29.99.

Urinary and Male Genital Tumours (WHO Classification of Tumours, 8)

Original price was: $180.00.Current price is: $29.99.

The 5th edition of WHO’s Urinary and Male Genital Tumours is authoritative and essential for cancer care professionals, with 900+ images.

Safe Secure Checkout
19 People watching this product now!
Description

*When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers, and if there are quality issues, please get in touch with the seller for a refund.*****

Urinary and Male Genital Tumours is Volume 8 in the 5th edition of the WHO series on the classification of human tumors.

This series (the WHO Blue Books) is the gold standard for diagnosing tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of cancer patients or cancer research. They underpin individual patient treatment and research into all aspects of cancer causation, prevention, therapy, and education.

What’s new in this edition?

The 5th edition, guided by the WHO Classification of Tumours Editorial Board, will establish a single coherent cancer classification presented across a collection of individual volumes organized based on anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured systematically, with each tumor type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are listed from benign to malignant. They are described under updated headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria.

Who should read this book?

  • Pathologists
  • Urologists
  • Radiologists
  • Medical oncologists
  • Radiation oncologists
  • Surgeons
  • Oncology nurses
  • Cancer researchers
  • Epidemiologists
  • Cancer registrars

This volume:

  • Prepared by 181 authors and editors
  • Contributors from around the world
  • More than 900 high-quality images
  • More than 3600 references